Sort
39,280 grants matching “leukemia”
Immunology And Pathology Of Murine Leukemia Virus Infections
$2,036,332Kim Hasenkrug · Niaid Extramural Activities · Z01 · FY2007 · AI
Immunogenetics of Graft-Versus-Host Disease
$2,035,982Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Specialized Program Of Research Excellence (SPORE) in Leukemia.
$2,035,962Daniel C Link · Washington University · P50 · FY2021 · CA
University of New Mexico Cancer Center Support
$2,035,899Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2010 · CA
Hematopoietic Stem Cells for Transplantation
$2,035,680Curt I Civin · Johns Hopkins University · P01 · FY2008 · CA
Mechanisms of GVHD
$2,035,506Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2006 · HL
Development of New Antitumor Agents
$2,034,948Southern Research Institute · P01 · FY2001 · CA
Mechanisms of GVHD
$2,034,180Dana-Farber Cancer Institute · P01 · FY2005 · HL
Immunologic Approaches to Ovarian Cancer
$2,033,832Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2018 · CA
Immunologic Approaches to Ovarian Cancer
$2,033,832Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Immunologic Approaches to Ovarian Cancer
$2,033,832David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$2,032,463Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Molecular Profiling of Clinical Specimens
$2,032,400Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Loss of miR-29s as predictor of response to demethylating agents
$2,031,555Carlo M Croce · Ohio State University · RC2 · FY2009 · CA
Developmental Therapeutics Program
$2,029,064James V Degregori · University Of Colorado Denver · P30 · FY2025 · CA
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
$2,029,001Mark A Watson · Washington University · U24 · FY2017 · CA
Molecular Pathways to Thynmic Lymphoma and Leukemia
$2,028,518A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$2,026,942Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Loss of miR-29s as predictor of response to demethylating agents
$2,026,079Carlo M Croce · Ohio State University · RC2 · FY2010 · CA
Mechanisms of GVHD
$2,025,615Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2007 · HL
Hematopoietic Chimerism after Stem Cell Allografts
$2,023,730Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2017 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$2,023,730Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA
Molecular Pathways to Thynmic Lymphoma and Leukemia
$2,022,365A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Targeted Sphingolipid Metabolism for Treatment of AML
$2,019,502Thomas P Loughran · University Of Virginia · P01 · FY2017 · CA
Targeted Sphingolipid Metabolism for Treatment of AML
$2,019,502Thomas P Loughran · University Of Virginia · P01 · FY2016 · CA